Pantoprazol Aurobindo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurobindo, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Pantoprazol Aurobindo is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive esophagitis: heals mucosal damage caused by chronic acid exposure. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Maintenance therapy after ulcer healing: helps prevent recurrence of ulceration.

Pantoprazol Aurobindo may cause a range of adverse reactions. Most are mild and reversible, but rare events can be serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with reduced function. - Severe hypersensitivity: rash, angioedema, or anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Vitamin B12 deficiency: may develop after prolonged therapy. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Before initiating Pantoprazol Aurobindo, consider the following safety measures: - Assess renal function: dose adjustment may be needed in severe impairment. - Review hepatic status: use with caution in moderate liver disease. - Evaluate for infections: monitor for C. difficile if prolonged therapy is planned. - Consider bone health: assess fracture risk in long‑term users. - Pregnancy and lactation: prescribe only if benefit outweighs risk. - Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture.

Pantoprazol Aurobindo can affect the plasma concentrations of several co‑administered medicines. Monitoring and dose adjustments may be required.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): markedly reduced absorption. - HIV protease inhibitors (e.g., atazanavir): decreased serum levels. - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer monitoring. - Methotrexate: possible accumulation, especially in renal impairment. - Digoxin: slight rise in serum concentration. - Oral contraceptives: may slightly reduce efficacy.